Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated δ12-PGJ2 acting through PPARγ-dependent and independent pathways

Gene

Volumn 505, Issue 1, 2012, Pages 46-52

  Fujimori, Ko ^a   Maruyama, Toshihiko ^b   Kamauchi, Shinya ^b   Urade, Yoshihiro ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

12 PGJ2; 3T3 L1; Adipocytokines; L PGDS; PPAR ; PPARAdipocytes

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 4 DIBENZO[A,D]CYCLOHEPTEN 5 YLIDENE 1 [4 (2H TETRAZOL 5 YL)BUTYL]PIPERIDINE; ACYL COENZYME A DESATURASE; ADIPONECTIN; FATTY ACID BINDING PROTEIN 4; LEPTIN; LIPOCALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIPERIDINE DERIVATIVE; PROSTAGLANDIN D SYNTHASE; SMALL INTERFERING RNA; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOGENESIS; ANILIDES; ANIMALS; CHROMANS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MICE; PPAR GAMMA; PROSTAGLANDIN D2; THIAZOLIDINEDIONES;

MAMMALIA;

EID: 84863880589     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.05.052     Document Type: Article

References (32)

1. Akerstrom B., Borregaard N., Flower D.R., Salier J.-P. Lipocalins 2006, Landes Biosciences, Georgetown, TX, USA.
2. Antuna-Puente B., Feve B., Fellahi S., Bastard J.P. Adipokines: the missing link between insulin resistance and obesity. Diab. Metab. 2008, 34:2-11.
3. Attie A.D., Scherer P.E. Adipocyte metabolism and obesity. J. Lipid Res. 2009, 50:S395-S399. Suppl.
4. Bell-Parikh L.C., Ide T., Lawson J.A., McNamara P., Reilly M., FitzGerald G.A. Biosynthesis of 15-deoxy-δ12,14-PGJ2 and the ligation of PPARγ. J. Clin. Invest. 2003, 112:945-955.
5. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
6. Casimir D.A., Miller C.W., Ntambi J.M. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation 1996, 60:203-210.
7. Farooqi I.S., O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am. J. Clin. Nutr. 2009, 89:980S-984S.
8. Fitzpatrick F.A., Wynalda M.A. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 1983, 258:11713-11718.
9. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995, 83:803-812.
10. Fujimori K., Kadoyama K., Urade Y. Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of Notch-HES signaling and enhancement of AP-2β function in brain-derived TE671 cells. J. Biol. Chem. 2005, 280:18452-18461.
11. Fujimori K., Aritake K., Urade Y. A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J. Biol. Chem. 2007, 282:18458-18466.
12. Fujimori K., et al. Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2α synthase. J. Biol. Chem. 2010, 285:8880-8886.
13. 2 in vivo. FEBS J. 2010, 277:1410-1419.
14. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010, 316:129-139.
15. Hossain M.S., Chowdhury A.A., Rahman M.S., Nishimura K., Jisaka M., Nagaya T., Shono F., Yokota K. Development of enzyme-linked immunosorbent assay for δ12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. Prostaglandins Other Lipid Mediat. 2011, 94:73-80.
16. Ii H., Hatakeyama S., Tsutsumi K., Sato T., Akiba S. Group IVA phospholipase A2 is associated with the storage of lipids in adipose tissue and liver. Prostaglandins Other Lipid Mediat. 2008, 86:12-17.
17. 2-knockout mice. PLoS One 2009, 4:e8089.
18. Irikura D., Aritake K., Nagata N., Maruyama T., Shimamoto S., Urade Y. Biochemical functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. J. Biol. Chem. 2009, 284:7623-7630.
19. Kikawa Y., Narumiya S., Fukushima M., Wakatsuka H., Hayaishi O. 9-Deoxy-δ9, δ12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:1317-1321.
20. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995, 83:813-819.
21. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20:107-114.
22. Maeda N., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8:731-737.
23. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr. Pharm. Des. 2010, 16:1896-1901.
24. 2α. Endocrinology 1996, 137:5641-5650.
25. 2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. Pflugers Arch. 2006, 453:177-187.
26. Rasouli N., Kern P.A. Adipocytokines the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008, 93:S64-S73.
27. Rosen E., Eguchi J., Xu Z. Transcriptional targets in adipocyte biology. Expert Opin. Ther. Targets 2009, 13:975-986.
28. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
29. Stumvoll M. Thiazolidinediones-some recent developments. Expert Opin. Investig. Drugs 2003, 12:1179-1187.
30. Tsuboi H., Sugimoto Y., Kainoh T., Ichikawa A. Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Commun. 2004, 322:1066-1072.
31. White U.A., Stephens J.M. Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 2010, 318:10-14.
32. Xie Y., et al. Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diab. Obes. Metab. 2006, 8:83-93.